The role of glutamate in the neurotoxic effects of methamphetamine

Annals of the New York Academy of Sciences

Volumn 801, Issue , 1996, Pages 315-326

  Ohmori, T ^a   Abekawa, T ^a   Koyama, T ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; GLUTAMIC ACID; METHAMPHETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; MALE; MICRODIALYSIS; NEUROCHEMISTRY; NEUROTOXICITY; NEUROTRANSMISSION; NONHUMAN; NUCLEUS ACCUMBENS; RAT;

ANIMALIA;

EID: 0030479802     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb17452.x     Document Type: Conference Paper

References (22)

1. SEIDEN, L. S., M. W. FISCHMAN & C. R. SCHUSTER. 1975/76. Long-term methamphetamine induced changes in brain catecholamines in tolerant rhesus monkeys. Drug Alcohol Depend. 1: 215-219.
2. HOTCHKISS, A. J. & J. W. GIBB. 1980. Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain. J. Pharmacol. Exp. Ther. 214: 257-262.
3. RICAURTE, G. A., C. R. SCHUSTER & L. S. SEIDEN. 1980. Long-term effects of repeated methamphetamine administration on dopamine and serotonin neurons in the rat brain: a regional study. Brain Res. 193: 153-163.
4. BAKHIT, C., M. E. MORGAN, M. A. PEAT & J. W. GIBB. 1981. Long-term effects of methamphetamine on the synthesis and metabolism of 5-hydroxytryptamine in various regions of the rat brain. Neuropharmacology 20: 1135-1140.
5. BUENING, M. K. & J. W. GIBB. 1974. Influence of methamphetamine and neuroleptic drugs on tyrosine hydroxylase activity. Eur. J. Pharmacol. 26: 30-34.
6. SCHMIDT, C. J., J. K. RITTER, P. K. SONSALLA, G. R. HANSON & J. W. GIBB. 1985. Role of dopamine in the neurotoxic effects of methamphetamine. J. Pharmacol. Exp. Ther. 233: 539-544.
7. JOHNSON, M., D. M. STONE, G. R. HANSON & J. W. GIBB. 1987. Role of the dopaminergic nigrostriatal pathway in methamphetamine-induced depression of the neostriatal serotonergic system. Eur. J. Pharmacol. 135: 231-234.
8. O'DELL, S. J., F. B. WEIHMULLER & J. F. MARSHALL. 1991. Multiple methamphetamine injections induce marked increases in extracellular striatal dopamine which correlate with subsequent neurotoxicity. Brain Res. 564: 256-260.
9. SONSALLA, P. K., W. J. NICKLAS & R. E. HEIKKILA. 1989. Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity. Science 243: 398-400.
10. SONSALLA, P. K., D. E. RIORDAN & R. E. HEIKKILA. 1991. Competitive and noncompetitive antagonists at N-methyl-D-aspartate receptors protect against methamphetamine-induced dopaminergic damage in mice. J. Pharmacol. Exp. Ther. 256: 506-512.
11. JOHNSON, M., G. R. HANSON & J. W. GIBB. 1989. Effect of MK-801 on the decrease in tryptophan hydroxylase induced by methamphetamine and its methylenedioxy analog. Eur. J. Pharmacol. 165: 315-318.
12. NASH, J. F. & B. K. YAMAMOTO. 1992. Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3,4-methylenedioxymethamphetamine. Brain Res. 581: 237-243.
13. OHMORI, T., T. KOYAMA, A. MURAKI & I. YAMASHITA. 1993. Competitive and noncompetitive N-methyl-D-aspartate antagonists protect dopaminergic and serotonergic neurotoxicity produced by methamphetamine in various brain regions. J. Neural Transm. 92: 97-106.
14. ABEKAWA, T., T. OHMORI & T. KOYAMA. 1994. Effects of repeated administration of a high dose of methamphetamine on dopamine and glutamate release in rat striatum and nucleus accumbens. Brain Res. 643: 276-281.
15. GREEN, A. R., R. J. DE SOUZA, J. L. WILLIAMS, T. K. MURRAY & A. J. CROSS. 1992. The neurotoxic effects of methamphetamine on 5-hydroxytryptamine and dopamine in brain: evidence for the protective effect of chlormethiazole. Neuropharmacology 31: 315-321.
16. BOWYER, J. F., A. W. TANK, G. D. NEWPORT, W. SLIKKER, JR., S. F. ALI & R. R. HOLSON. 1992. The influence of environmental temperature on the transient effects of methamphetamine on dopamine levels and dopamine release in rat striatum. J. Pharmacol. Exp. Ther. 260: 817-824.
17. ALI, S. F., G. D. NEWPORT, R. R. HOLSON, W. SLIKKER, JR. & J. F. BOWYER. 1994. Low environmental temperatures or pharmacologic agents that produce hypothermia decrease methamphetamine neurotoxicity in mice. Brain Res. 658: 33-38.
18. BOWYER, J. F., D. L. DAVIS, L. SCHMUED, H. W. BROENING, G. D. NEWPORT, W. SLIKKER, JR. & R. R. HOLSON. 1994. Further studies of the role of hyperthermia in methamphetamine neurotoxicity. J. Pharmacol. Exp. Ther. 268: 1571-1580.
19. KARLER, R., L. D. CALDER, I. A. CHAUDHRY & S. A. TURKANIS. 1989. Blockade of reverse tolerance to cocaine and amphetamine by MK-801. Life Sci. 45: 599-606.
20. WOLF, M. E. & M. R. KHASA. 1991. Repeated administration of MK-801 produces sensitization to its own locomotor stimulant effects but blocks sensitization to amphetamine. Brain Res. 562: 164-168.
21. STEWART, J. & J. DRUHAN. 1993. Development of both conditioning and sensitization of the behavioral activating effects of amphetamine is blocked by the non-competitive NMDA receptor antagonist, MK-801. Psychopharmacology 110: 125-132.
22. OHMORI, T., T. ABEKAWA & T. KOYAMA. 1994. Competitive and noncompetitive NMDA antagonists prevent sensitization to methamphetamine. Pharmacol. Biochem. Behav. 48: 587-591.